http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104224831-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
filingDate 2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104224831-B
titleOfInvention Preparation method of folic acid class nutrient supplement
abstract The invention relates to a preparation method of a folic acid class nutrient supplement and belongs to the technical field of medicines. According to the method, folic acid, ferrous fumarate and pharmaceutical adjuvants are evenly mixed together through a special preparation technology and instruments and equipment and prepared into nutrient supplement class tablets which are uniform in content and stable and can decompose quickly to release functional components to solve the problems that the functional components of the folic acid and the ferrous fumarate are greatly different in mass and prone to uneven distribution to cause an uneven product content, and to solve the technical problems that the folic acid is unstable in property when being exposed to light and the ferrous fumarate is prone to oxidization when being exposed to air to cause disintegration and poor dissolution. According to the preparation method, by changing the adding mode of the folic acid and adding the procedure of coating, the uniformity and the stability of the functional components are guaranteed; the method is simple in technological operation and applicable to industrial production; the content of the folic acid and the content of iron of the nutrient supplement are appropriate, so that the nutrient supplement is applicable to women of childbearing age and pregnant women.
priorityDate 2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451814683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559466

Total number of triples: 27.